D-0500-2025 Class II Ongoing
FDA drug recall D-0500-2025 was initiated by Tailstorm Health INC on Jun 2, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process. The recall status is ongoing. Affected quantity: 23,200 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 9, 2025
- Initiation Date
- Jun 2, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23,200 vials
Product description
KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.
Reason for recall
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Distribution pattern
Nationwide in the US
Code information
Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0500-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026